BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 20410079)

  • 1. Cervical infection with human papillomavirus (HPV) 6 or 11 in high-risk women in Burkina Faso.
    Low A; Didelot-Rousseau MN; Nagot N; Ouedraougo A; Clayton T; Konate I; Van de Perre P; Segondy M; Mayaud P
    Sex Transm Infect; 2010 Oct; 86(5):342-4. PubMed ID: 20410079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anal and cervical human papillomavirus infection and risk of anal and cervical epithelial abnormalities in human immunodeficiency virus-infected women.
    Williams AB; Darragh TM; Vranizan K; Ochia C; Moss AR; Palefsky JM
    Obstet Gynecol; 1994 Feb; 83(2):205-11. PubMed ID: 8290181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genital warts and infection with human immunodeficiency virus in high-risk women in Burkina Faso: a longitudinal study.
    Low AJ; Clayton T; Konate I; Nagot N; Ouedraogo A; Huet C; Didelot-Rousseau MN; Segondy M; Van de Perre P; Mayaud P;
    BMC Infect Dis; 2011 Jan; 11():20. PubMed ID: 21251265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genital human papillomavirus prevalence and human papillomavirus concordance in heterosexual couples are positively associated with human immunodeficiency virus coinfection.
    Mbulawa ZZ; Coetzee D; Marais DJ; Kamupira M; Zwane E; Allan B; Constant D; Moodley JR; Hoffman M; Williamson AL
    J Infect Dis; 2009 May; 199(10):1514-24. PubMed ID: 19392625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.
    Palefsky JM; Holly EA; Ralston ML; Da Costa M ; Greenblatt RM
    J Infect Dis; 2001 Feb; 183(3):383-91. PubMed ID: 11133369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prevalence of oncogenic human papillomavirus in the genital tract of women with human immunodeficiency virus.
    Volkow P; Rubí S; Lizano M; Carrillo A; Vilar-Compte D; García-Carrancá A; Sotelo R; García B; Sierra-Madero J; Mohar A
    Gynecol Oncol; 2001 Jul; 82(1):27-31. PubMed ID: 11426958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of risk factors associated with human papillomavirus infection in women living with HIV. Canadian Women's HIV Study Group.
    Hankins C; Coutlée F; Lapointe N; Simard P; Tran T; Samson J; Hum L
    CMAJ; 1999 Jan; 160(2):185-91. PubMed ID: 9951439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic and therapeutic concepts of HPV infection in HIV-positive women].
    Küppers V; von Eckardstein S; Adomeit A; Wingartz C; Bodden-Heidrich R; Koldovsky U; Bender HG
    Zentralbl Gynakol; 1999; 121(1):27-30. PubMed ID: 10091310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infection with human papillomavirus and HIV among young women in Kampala, Uganda.
    Banura C; Franceschi S; Doorn LJ; Arslan A; Wabwire-Mangen F; Mbidde EK; Quint W; Weiderpass E
    J Infect Dis; 2008 Feb; 197(4):555-62. PubMed ID: 18237268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of human papillomavirus infection and associated risk factors in young women in Brazil, Canada, and the United States: a multicenter cross-sectional study.
    Roteli-Martins CM; de Carvalho NS; Naud P; Teixeira J; Borba P; Derchain S; Tyring S; Gall S; Diaz A; Blatter M; Shier RM; Romanowski B; Quint WG; Issam J; Galindo C; Schuind A; Dubin G
    Int J Gynecol Pathol; 2011 Mar; 30(2):173-84. PubMed ID: 21293281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.
    Branca M; Garbuglia AR; Benedetto A; Cappiello T; Leoncini L; Migliore G; Agarossi A; Syrjänen K;
    Int J STD AIDS; 2003 Jun; 14(6):417-25. PubMed ID: 12816671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of bacterial vaginosis and other genital infections on the natural history of human papillomavirus infection in HIV-1-infected and high-risk HIV-1-uninfected women.
    Watts DH; Fazzari M; Minkoff H; Hillier SL; Sha B; Glesby M; Levine AM; Burk R; Palefsky JM; Moxley M; Ahdieh-Grant L; Strickler HD
    J Infect Dis; 2005 Apr; 191(7):1129-39. PubMed ID: 15747249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2.
    Hawes SE; Critchlow CW; Sow PS; Touré P; N'Doye I; Diop A; Kuypers JM; Kasse AA; Kiviat NB
    J Natl Cancer Inst; 2006 Jan; 98(2):100-9. PubMed ID: 16418512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and predictors of human papillomavirus-6, -11, -16, and -18 infection in young norwegian women.
    Kim S; Arduino JM; Roberts CC; Marsico M; Liaw KL; Skjeldestad FE
    Sex Transm Dis; 2011 Jul; 38(7):587-97. PubMed ID: 21301390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papilloma virus types in the oral and cervical mucosa of HIV-positive South African women prior to antiretroviral therapy.
    Richter KL; van Rensburg EJ; van Heerden WF; Boy SC
    J Oral Pathol Med; 2008 Oct; 37(9):555-9. PubMed ID: 18355174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral polymorphism in human papillomavirus types 33 and 35 and persistent and transient infection in the genital tract of women.
    Gagnon S; Hankins C; Tremblay C; Forest P; Pourreaux K; Coutlée F;
    J Infect Dis; 2004 Nov; 190(9):1575-85. PubMed ID: 15478061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical and oral human papillomavirus types in HIV-1 positive and negative women with cervical disease in South Africa.
    Marais DJ; Passmore JA; Denny L; Sampson C; Allan BR; Williamson AL
    J Med Virol; 2008 Jun; 80(6):953-9. PubMed ID: 18428143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for cervical neoplasia in Denmark.
    Kjaer SK
    APMIS Suppl; 1998; 80():1-41. PubMed ID: 9693662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and duration of cervical human papillomavirus 6, 11, 16, and 18 infections in young women: an evaluation from multiple analytic perspectives.
    Insinga RP; Dasbach EJ; Elbasha EH; Liaw KL; Barr E
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):709-15. PubMed ID: 17416761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with increased prevalence of human papillomavirus infection in a cohort of HIV-infected Brazilian women.
    Grinsztejn B; Veloso VG; Levi JE; Velasque L; Luz PM; Friedman RK; Andrade AC; Moreira RI; Russomano F; Pilotto JH; Bastos FI; Palefsky J
    Int J Infect Dis; 2009 Jan; 13(1):72-80. PubMed ID: 18632296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.